Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Malnutrition 4Esophageal Neoplasms 3Head and Neck Neoplasms 2Weight Loss 1Stomach Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Nutritional Support 1Neoplasms, Plasma Cell 1Neoplasms 1Nasopharyngeal Carcinoma 1Muscular Atrophy 1Lymphoma 1Hyperphagia 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Digestive System Neoplasms 1Deglutition Disorders 1Critical Illness 1Child Nutrition Disorders 1Cachexia 1

Interventions

ostarine 3rimabotulinumtoxinB 1Standard of Care 1Olanzapine 1Enteral Nutrition 1Cyproheptadine 1Creatine 1Botulinum Toxins, Type A 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Muscular Atrophy × Enteral Nutrition × Clear all
NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed
19 enrolled

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡